AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2008
Feb 29, 2008
35599_dirs_2008-02-29_43c130f8-64bf-42d4-915c-4e0ad2fbf12c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2008-02-27
Reporting Person: NORRIS ROBIN J (Director, President & COO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-27 | Stock Options (Right to buy) | $0.38 | A | 400000 | Acquired | 2015-02-27 | Common Stock (400000) | Direct |
Footnotes
F1: The options to which this note relates vested 100% on the date reported above.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20